March 20 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- ANNOUNCES ITS INTENTION TO MAKE AN OFF-MARKET TAKEOVER OFFER TO ACQUIRE HEALIUS LIMITED
- OFFER WILL BE MADE BY WAY OF AN OFF-MARKET TAKEOVER OFFER BY ACL TO ACQUIRE ALL OF HEALIUS SHARES ON ISSUE
- ACL'S OFFER IS 0.74 ACL SHARES FOR EVERY 1 HEALIUS SHARE HELD
- IF ACL SUCCESSFUL IN ACQUIRING ALL OF HEALIUS SHARES ON ISSUE UNDER OFFER, HEALIUS SHAREHOLDERS WILL HOLD ABOUT 68% OF ACL
- ACL EXPECTS THAT ITS EBIT FOR FY23 WILL BE WITHIN RANGE OF A$68 MILLION AND A$74 MILLION
- MATERIAL SYNERGY POTENTIAL OF A$95 MILLION BY BRINGING COMPANIES TOGETHER
- POTENTIAL MERGED GROUP PRO FORMA FY23 EBIT OF A$361 MILLION INCLUDING EXPECTED COST SYNERGIES
(([email protected];))
March 20 (Reuters) - Australian Clinical Labs Ltd (ACL) :...
Add ACL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.25 |
Change
-0.030(1.32%) |
Mkt cap ! $454.1M | |||
| Open | High | Low | Value | Volume |
| $2.28 | $2.28 | $2.19 | $1.902M | 853.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4672 | $2.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.27 | 3500 | 1 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.26 |
Change
-0.030 ( 0.78 %) |
||||
| Open | High | Low | Volume | ||
| $2.28 | $2.28 | $2.20 | 141881 | ||
| Last updated 15.59pm 05/06/2024 ? | |||||
| ACL (ASX) Chart |